{"protocolSection":{"identificationModule":{"nctId":"NCT04259307","orgStudyIdInfo":{"id":"2019-06-109"},"organization":{"fullName":"Samsung Medical Center","class":"OTHER"},"briefTitle":"Effect of Intensive Nutritional Support in Subacute Stroke Patient","officialTitle":"Effect of Intensive Nutritional Support on Functional Recovery in Subacute Stroke Patient"},"statusModule":{"statusVerifiedDate":"2022-05","overallStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2020-01-29","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2023-08-31","type":"ESTIMATED"},"completionDateStruct":{"date":"2023-12-31","type":"ESTIMATED"},"studyFirstSubmitDate":"2020-02-04","studyFirstSubmitQcDate":"2020-02-04","studyFirstPostDateStruct":{"date":"2020-02-06","type":"ACTUAL"},"lastUpdateSubmitDate":"2022-05-05","lastUpdatePostDateStruct":{"date":"2022-05-09","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Won Hyuk Chang","investigatorTitle":"Associate Professor","investigatorAffiliation":"Samsung Medical Center"},"leadSponsor":{"name":"Samsung Medical Center","class":"OTHER"},"collaborators":[{"name":"Korean Center for Disease Control and Prevention","class":"OTHER_GOV"}]},"oversightModule":{"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"Proper nutritional support during early rehabilitation may be beneficial for functional improvements in gaining functional independence and preventing complications in stroke patients. However, there was no consensus of proper amount of nutritional support in stroke patients. In this study, the investigators aimed to clarigy the effects of the intensive nutritional support during comprehensive rehabilitation during subacute phase to improve function in patients with first-ever strokes."},"conditionsModule":{"conditions":["Stroke","Rehabilitation","Nutrition"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"SINGLE","whoMasked":["OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":150,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Intensive nutrition group","type":"EXPERIMENTAL","description":"Standard nutritional support with additional intravenous nutrition of 500 kcal per day for 3 weeks","interventionNames":["Drug: Omapone Peri 724mL or Winuf Peri 654mL"]},{"label":"Control group","type":"NO_INTERVENTION","description":"Standard nutritional support only per day for 3 weeks"}],"interventions":[{"type":"DRUG","name":"Omapone Peri 724mL or Winuf Peri 654mL","description":"Additional intravenous nutrition of 500 kcal per day for 3 weeks","armGroupLabels":["Intensive nutrition group"],"otherNames":["Comprehensive rehabilitation"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Korean modified Barthel Index (K-MBI) at 6 months after onset","description":"Korean modified Barthel Index (0\\~100)","timeFrame":"6 months after onset"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Acute first-ever stroke patients less than 7 days after onset\n\n  * more than 19 years old at stroke onset ③ stroke confirmed by brain CT or MRI\n\n    * body mass index (BMI) \\<25 before the comprehensive rehabilitation ⑤ Mini Nutritional Assessment \\< 12 before the comprehensive rehabilitation ⑥ Fugl-Meyer assessment \\< 85 at 7 days after stroke onset\n\nExclusion Criteria:\n\n* Transient ischemic stroke\n\n  * Progressive or unstable stroke\n\n    * Pre-existing and active major neurological disease, e.g., spinal cord injury, Parkinson's disease, et al.\n\n      * Pre-existing and active (e.g., on chronic medication) major psychiatric disease, such as major depression, schizophrenia, bipolar disease or dementia ⑤ Advanced liver, kidney, cardiac, or pulmonary disease, e.g., advanced hepatocellular carcinoma, end-stage renal failure, et al.)\n\n        * A terminal medical diagnosis consistent with survival \\< 1 year\n\n          * Diabetes mellitus, Hyperlipidemia, Metabolic syndrome, Heart failure) ⑧ Pregnant or lactating women ⑨ Prohibited from taking medication (Omapone Peri 724mL or Winuf Peri 654mL)","healthyVolunteers":false,"sex":"ALL","minimumAge":"19 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"centralContacts":[{"name":"Won Hyuk Chang, MD.,PhD.","role":"CONTACT","phone":"82-2-3410-6068","email":"wh.chang@samsung.com"}],"locations":[{"facility":"Samsung Medical Center","status":"RECRUITING","city":"Seoul","zip":"135-710","country":"Korea, Republic of","contacts":[{"name":"Won Hyuk Chang, Prof","role":"CONTACT","phone":"82-2-3410-6068","email":"wh.chang@samsung.com"}],"geoPoint":{"lat":37.566,"lon":126.9784}}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"}]}},"hasResults":false}